Noninvasive markers of liver fibrosis and inflammation in chronic hepatitis B-virus related liver disease

American Journal of Gastroenterology

Volumn 101, Issue 11, 2006, Pages 2537-2545

  Mohamadnejad, Mehdi ^a,b   Montazeri, Ghodrat ^a   Fazlollahi, Atoosa ^a   Zamani, Farhad ^b   Nasiri, Jafar ^a   Nobakht, Hossein ^a   Forouzanfar, Mohammad Hossein ^c   Abedian, Shifteh ^a   Tavangar, Seyed Mohamad ^d   Mohamadkhani, Ashraf ^a   Ghoujeghi, Farhad ^a   Estakhri, Arezoo ^a   Nouri, Negin ^a   Farzadi, Zahra ^a   Najjari, Abolfazl ^b   Malekzadeh, Reza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c School of Nursing and Mailman

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; INFLAMMATION; LIVER BIOPSY; LIVER DISEASE; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; THROMBOCYTE COUNT; TRAINING; VALIDATION PROCESS;

ADULT; AGE FACTORS; ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; DNA, VIRAL; FEMALE; HEPATITIS B E ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; INFLAMMATION; LIVER CIRRHOSIS; MALE; PLATELET COUNT; ROC CURVE; SERUM ALBUMIN;

EID: 33750497272     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2006.00788.x     Document Type: Article

References (28)

1. Lok AS, McMahon BJ. Practice Guidelines Committee, American Association for the Study of Liver Diseases. Chronic hepatitis B. Hepatology 2001;34:1225-41.
2. Lok AS. Overview of the treatment of chronic hepatitis B and case examples. In: Up to Date 13.1. DB Rose (CDROM). Washington, DC: Up to date, 2005.
3. Martinot-Peignoux M, Boyer N, Colombat M, et al. Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers. J Hepatol 2002;36:543-6.
4. Hsu YS, Chien RN, Yeh CT, et al. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology 2002;35:1522-7.
5. Yuen MF, Yuan HJ, Wong DK, et al. Prognostic determinants for chronic hepatitis B in Asians: Therapeutic implications. Gut 2005;54:1610-4.
6. Manesis EK, Papatheodoridis GV, Hadziyannis SJ. Serum HBV-DNA levels in inactive hepatitis B virus carriers. Gastroenterology 2002;122:2092-3; author reply 2093.
7. Keeffe EB, Dieterich DT, Han SH, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States. Clin Gastroenterol Hepatol 2004;2:87-106.
8. Sherman M. Predicting survival in hepatitis B. Gut 2005;54:1521-3.
9. Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: Results of a prospective nationwide survey. Hepatology 2000;32:477-81.
10. Fontana RJ, Lok AS. Noninvasive monitoring of patients with chronic hepatitis C. Hepatology 2002;36:S57-64.
11. Rosenberg WM, Voelker M, Thiel R, et al. Serum markers detect the presence of liver fibrosis: A cohort study. Gastroenterology 2004;127:1704-13.
12. Imbert-Bismut F, Ratziu V, Pieroni L, et al. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: A prospective study. Lancet 2001;357:1069-75.
13. Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003;38:518-26.
14. Le Calvez S, Thabut D, Messous D, et al. The predictive value of Fibrotest vs. APRI for the diagnosis of fibrosis in chronic hepatitis C. Hepatology 2004;39:862-3; author reply 863.
15. Myers RP, Tainturier MH, Ratziu V, et al. Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B. J Hepatol 2003;39:222-30.
16. Montazeri G, Estakhri A, Mohamadnejad M, et al. Serum hyaluronate as a non-invasive marker of hepatic fibrosis and inflammation in HBeAg-negative chronic hepatitis B. BMC Gastroenterol 2005;5:32.
17. Hui AY, Chan HL, Wong VW, et al. Identification of chronic hepatitis B patients without significant liver fibrosis by a simple noninvasive predictive model. Am J Gastroenterol 2005;100:616-23.
18. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696-9.
19. McHutchison JG, Blatt LM, de Medina M, et al. Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology. Consensus Interferon Study Group. J Gastroenterol Hepatol 2000;15:945-51.
20. Iloeje UH, Yang HI, Su J, et al. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology 2006;130:678-86.
21. Chen G, Lin W, Shen FM, et al. Viral load as a predictor of liver disease in chronic hepatitis B infection. Hepatology 2005;40(suppl 1):594A.
22. Manesis EK, Papatheodoridis GV, Sevastianos V, et al. Significance of hepatitis B viremia levels determined by a quantitative polymerase chain reaction assay in patients with hepatitis B e antigen-negative chronic hepatitis B virus infection. Am J Gastroenterol 2003;98:2261-7.
23. Fattovich G. Natural history of hepatitis B. J Hepatol 2003;39:50-8.
24. Chu CJ, Hussain M, Lok AS. Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection. Hepatology 2002;36:1408-15.
25. Chang MH, Hwang LY, Hsu HC, et al. Prospective study of asymptomatic HBs Ag carrier children infected in the perinatal period: Clinical and liver histologic studies. Hepatology 1998;8:374-7.
26. Yuen MF, Ng IO, Fan ST, et al. Significance of HBV DNA levels in liver histology of HBeAg and anti-HBe positive patients with chronic hepatitis B. Am J Gastroenterol 2004;99:2032-7.
27. Papatheodoridis GV, Hadziyannis SJ. Review article: Current management of chronic hepatitis B. Aliment Pharmacol Ther 2004;19:25-37.
28. Poynard T, Ratziu V, Benhamou Y, et al. Biomarkers as a first-line estimate of injury in chronic liver diseases: Time for a moratorium on liver biopsy?. Gastroenterology 2005;128:1146-8; author reply 1148.